<DOC>
	<DOCNO>NCT00398918</DOCNO>
	<brief_summary>This pilot study intent establish alcohol administration laboratory able test effect anticonvulsant medication zonisamide compare placebo alcohol self administration cognitive function non treatment seek heavy user alcohol . Our first goal establish safety zonisamide use together alcohol . Our second goal test effect acute dose zonisamide alcohol consumption show may reduce consumption alcohol . To achieve goal seek subject history heavy drinking test self-administration procedure describe two session either zonisamide placebo . These procedure involve first , administration challenge dose ethanol evaluate effect alcohol performance neuropsychological test . This initial challenge follow period alcohol self-administration research subject choose select either ethanol another reinforcer , money .</brief_summary>
	<brief_title>Alcohol Self Administration Laboratory</brief_title>
	<detailed_description>In preclinical study three novel anticonvulsant study . The administration tiagabine decrease ethanol consumption rodent ( Schmitt et al. , 2002 ; Rimondini et al. , 2002 ) . In study alcohol prefer mouse topiramate reduce alcohol consumption two bottle choice prolong access model drinking ( Gabriel Cunningham , 2005 ) . In study do laboratory topiramate zonisamide find similar effect reduce consumption ethanol Wistar rat ( Knapp et al. , 2004 ) . More recently find zonisamide administration decrease alcohol consumption limit access model C57BL/B6 mouse . These result suggest zonisamide might useful medication treatment alcohol dependence . Topiramate zonisamide structural similarity sulfamate methane-sulfonamide containing chain respectively attach cyclic structure . These structural similarity may explain pharmacological similarity include blockade voltage sensitive sodium channel low potency inhibition carbonic anhydrase ( Taverna et al. , 1999 ; Dodgson et al. , 2000 ; Schaf et al. , 1987 ; Masudaet al. , 1993 ) . Both topiramate zonisamide promote weight loss ( McElroy et al. , 2003 ; McElroy et al. , 2004 ; Gadde et al. , 2003 ) . This effect may result neuromodulation regulation alcohol food share drug .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>1 . Non treatment seek subject ages 2155 must indicate treatment alcohol dependence precede 6 month . 2 . Male subject must drink 40 standard drink ; female subject 35 standard drink week determine TLFB 3 . Subjects must able provide IC 4 . BAC must 0.000 time consent 5 . Female subject child bear potential must use acceptable method contraception include barrier spermicide , levonorgestrel implant , medroxyprogesterone , intrauterine progesterone contraceptive system complete abstinence surgical sterilization . Women use oral contraceptive must agree additional barrier method . 1 . Subject meeting DSMIVTR criterion axis I diagnosis require pharmacological treatment . 2 . Subject meeting substance dependence criterion substance alcohol nicotine . 3 . Positive urine toxicology screen opioids , cocaine , amphetamine , PCP , THC ( may repeat THC positive ) . 4 . History severe alcohol withdrawal . 5 . Any medical psychological condition opinion investigator preclude safe participation trial . These include history kidney stone past 10 year , significant liver disease AST ALT 3 time normal range . 6 . Concomitant medication alter pharmacodynamic/pharmacokinetic property study medication . Participant take follow medication : Amprenavir ; Atazanavir ; Clarithromycin ; Delavirdine ; Diclofenac ; Fosamprenavir ; Imatinib ; Indinavir ; Isoniazid ; Itraconazole ; Ketoconazole ; Miconazole ; Nefazodone ; Nelfinavir ; NiCARdipine ; Propofol ; Quinidine ; Ritonavir ; Telithromycin ; Phenytoin ; carbamazepine phenobarbital 7 . Subjects psychoactive medication must stable dose 3 month 8 . Female subject pregnant nursing . 9 . Subject facing future imprisonment . 10 . A known allergy zonisamide sulfa .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>